Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	31.59B
Revenue (ttm)	6.29B
Net Income (ttm)	1.04B
Shares Out	359.15M
EPS (ttm)	2.86
PE Ratio	31.28
Forward PE	24.55
Dividend	1.10 (1.23%)
Ex-Dividend Date	Jun 26, 2025

Volume	3,752,483
Average Volume	5,032,848
Open	95.50
Previous Close	91.00
Day's Range	88.46 - 95.50
52-Week Range	59.90 - 125.50
Beta	0.30
RSI	30.43
Earnings Date	Oct 30, 2025

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.